- Home
- Knowledge Base
- References
Cholera toxin B-saporin cytotoxicity is correlated with the extent of GM1 expression on the cell surface
Kohls MD, Lappi DA (2003) Cholera toxin B-saporin cytotoxicity is correlated with the extent of GM1 expression on the cell surface. Neuroscience 2003 Abstracts 325.16. Society for Neuroscience, New Orleans, LA.
Summary: Cholera toxin is composed of five B-subunits that mediate binding to the cell surface monosialoganglioside GM1, and one A-subunit that irreversibly activates adenylate cyclase. GM1 is found in high concentrations on astrocytes and the myelin of oligodendrocytes, as well as on many other cell types. A targeted toxin was developed consisting of the ribosome-inactivating protein saporin coupled to the B-subunit of cholera toxin (CTB) for the purpose of eliminating cells that express GM1. This targeted toxin (CTB-SAP) binds to cell-surface GM1 and the entire molecule is then internalized. Saporin separates from CTB and is released from the endosome to inactivate ribosomes. The cytoxicity of CTB-SAP in a cell-based in vitro assay can be inhibited by the addition of free CTB, indicating binding specificity. CTB-SAP has been tested on a variety of cell lines and the effectiveness of the targeted toxin correlates with the extent of GM1 cell surface expression as demonstrated by fluorescence-activated cell sorting (FACS) analysis. For example, using FACS analysis, RBL-2H3 cells exhibit an 88% shift when labeled with CTB-FITC. The ED50 of CTB-SAP in a cytoxicity assay on these cells is 380 fM, which corresponds to 9150 CTB-SAP molecules per cell. In comparison, HS294T cells produce a 48% shift in FACS, and the ED50 in the cytotoxicity assay is 5.5 pM. The correlation of surface GM1 number with ED50 indicates that the number of saporin molecules internalized is of primary importance in the process of cytotoxicity. CTB-SAP has been used to demyelinate the lumbar spinal cord (Jasmin et al.), eliminate sympathetic preganglionic neurons, and eliminate facial motoneurons in the rat (Llewellyn-Smith et al.). CTB-SAP is an effective and specific tool for the in vitro and in vivo elimination of cells that express GM1 on the cell surface.
Related Products: CTB-SAP (Cat. #IT-14)
Targeted toxins in pain.
Wiley RG, Lappi DA (2003) Targeted toxins in pain. Adv Drug Deliv Rev 55(8):1043-1054. doi: 10.1016/s0169-409x(03)00102-9
Summary: The authors discuss the use of ‘molecular neurosurgery’ in the study of nociception. Applications using targeted toxins, which include immunotoxins, protein-toxin conjugates, or peptide-toxin conjugates, are illustrated. The authors describe the use of these molecules as research tools, as well as their potential for therapeutics. A helpful table is included that lists neuronal surface markers and class of cells targeted for each targeted toxin. Reagents discussed: CTB-SAP (Cat. #IT-14), IB4-SAP (Cat. #IT-10), OX7-SAP (Cat. #IT-02), 192-Saporin (Cat. #IT-01), ME20.4-SAP (Cat. #IT-15), Anti-DBH-SAP (Cat. #IT-03), Anti-DAT-SAP (Cat. #IT-25), SP-SAP (Cat. #IT-07), Dermorphin-SAP (Cat. #IT-12), Orexin-SAP (Cat. #IT-20), CRF-SAP (Cat. #IT-13), and acetylated LDL-SAP (Cat. #IT-08).
Related Products: CTB-SAP (Cat. #IT-14), IB4-SAP (Cat. #IT-10), OX7-SAP (Cat. #IT-02), 192-IgG-SAP (Cat. #IT-01), ME20.4-SAP (Cat. #IT-15), Anti-DBH-SAP (Cat. #IT-03), Anti-DAT-SAP (Cat. #IT-25), SP-SAP (Cat. #IT-07), Dermorphin-SAP / MOR-SAP (Cat. #IT-12), Orexin-B-SAP (Cat. #IT-20), CRF-SAP (Cat. #IT-13), Acetylated LDL-SAP (Cat. #IT-08)
Androgen manipulation protects remaining motoneurons from dendritic atrophy after induced motoneuron death.
Fargo KN, Sengelaub DR (2002) Androgen manipulation protects remaining motoneurons from dendritic atrophy after induced motoneuron death. Neuroscience 2002 Abstracts 466.13. Society for Neuroscience, Orlando, FL.
Summary: Androgen treatment facilitates axon regrowth after axotomy of facial and sciatic motoneurons, and reverses castration-induced dendritic atrophy in motoneurons of the spinal nucleus of the bulbocavernosus (SNB) in rats. We assessed whether a similar therapeutic effect of androgen would be seen in dendrites following partial depletion of SNB motoneurons. We injected the toxin saporin, conjugated to choleratoxin (β-saporin), unilaterally into the SNB target muscles, bulbocavernosus (BC) and levator ani (LA), of two groups of adult male rats. One group had been castrated six weeks earlier to induce dendritic atrophy, and received testosterone-filled Silastic capsules coincident with β-saporin injection (SAP+T). The other group had no castration or androgen treatment (SAP-only). Four weeks after β-saporin injection, we injected choleratoxin conjugated HRP into the contralateral (non-saporin injected) BC muscle to label SNB motoneurons. A group of untreated normal males was also included. Cell counts were performed, and dendrites of HRP-labeled SNB motoneurons were reconstructed in three dimensions. β-saporin killed ~65% of motoneurons in the SNB ipsilateral to the saporin-injected muscles; contralateral SNB motoneuron numbers were not affected. SNB dendritic arbors on the non-saporin injected side were ~60% shorter in SAP-only animals compared to those of untreated males; in contrast, dendritic arbors in SAP+T animals were unaffected. These results indicate that a) motoneuron death causes dendritic atrophy in remaining SNB motoneurons, and that b) previous castration and concurrent testosterone replacement protects against this atrophy.
Related Products: CTB-SAP (Cat. #IT-14)
Schwann cells can enter the demyelinated spinal cord from dorsal roots via scar tissue.
Janni G, Jasmin L, Ohara PT (2001) Schwann cells can enter the demyelinated spinal cord from dorsal roots via scar tissue. Neuroscience 2001 Abstracts 157.4. Society for Neuroscience, San Diego, CA.
Summary: We have studied the routes of entry of Schwann cells into the demyelinated spinal cord. Following application of the toxin CTB-Sap (B fragment of Cholera toxin conjugated to Saporin) into the intrathecal space of adult rats there occurs massive loss of oligodendrocytes with secondary demyelination of the lumbar spinal cord with sparing of axons. Concurrent with the demyelination, an arachnoiditis develops that results in dorsal roots becoming adherent to the lateral spinal cord. Light and electron microscopy showed that Schwann cells in the dorsal roots were always separated from the demyelinated axons by a mesenchymal interface part of which was formed by the dorsal root perineurium. Within 15 days of the demyelination, Schwann cell precursors (p75 immunopositive) migrated from the dorsal roots into the spinal cord via the adhesions and were found to divide within the cord. Schwann cell myelination of demyelinated central axons was consistently observed by day 30. Therefore the Schwann precursors were able to migrate into demyelinated spinal cord through non-neuronal cellular barriers without being in direct contact with demyelinated axons. These findings suggest that, under appropriate conditions, Schwann cells might be introduced therapeutically into the demyelinated spinal cord via intrathecal application and avoid direct spinal injection.
Related Products: CTB-SAP (Cat. #IT-14)
Schwann cells are removed from the spinal cord after effecting recovery from paraplegia.
Jasmin L, Janni G, Moallem TM, Lappi DA, Ohara PT (2000) Schwann cells are removed from the spinal cord after effecting recovery from paraplegia. J Neurosci 20(24):9215-9223. doi: 10.1523/JNEUROSCI.20-24-09215.2000
Related Products: CTB-SAP (Cat. #IT-14)
Tracer-toxins: cholera toxin B-saporin as a model.
Llewellyn-Smith IJ, Martin CL, Arnolda LF, Minson JB (2000) Tracer-toxins: cholera toxin B-saporin as a model. J Neurosci Methods 103(1):83-90. doi: 10.1016/s0165-0270(00)00298-3 PMID: 11074098
Related Products: CTB-SAP (Cat. #IT-14), Cholera Toxin B, Recombinant (Cat. #PR-14)
Schwann cells are removed from the rat spinal cord after effecting recovery from paraplegia.
Janni G, Moallem T, Lappi DA, Ohara PT, Jasmin L (2000) Schwann cells are removed from the rat spinal cord after effecting recovery from paraplegia. Neuroscience 2000 Abstracts 516.8. Society for Neuroscience, New Orleans, LA.
Summary: Remyelination of the CNS is necessary to restore neural function in a number of demyelinating conditions such as multiple sclerosis. Schwann cells, the myelinating cells of the periphery, are good candidates for this purpose, having more robust regenerative properties than their central homologues, the oligodendrocytes. While the ability of Schwann cells to remyelinate the CNS and effect functional recovery has been demonstrated, their long term survival in the CNS after myelinating central axons is largely unknown. We use saporin conjugated to the cholera toxin B-subunit to demyelinate the rat lumbar spinal cord, remove macroglia, and produce paraplegia. This treatment is followed by a spontaneous proliferation of large numbers of endogenous Schwann cells which remyelinate spinal cord axons with concomitant functional recovery from paraplegia within 75 days. During the following weeks, however, quantification on thin sections shows that Schwann cells are progressively replaced by oligodendrocytes, without any lapse in behavioral recovery. This removal of Schwann cells is confirmed by ultrastructural examination and by immunocytochemistry for Schwann cells and oligodendrocytes. Our results indicate that Schwann cell remyelination of the spinal cord might not be permanent. They can be induced to demyelinate and desheath through endogenous mechanisms that remain to be characterized.
Related Products: CTB-SAP (Cat. #IT-14)
CTB-saporin induced demyelinating myelopathy in the rat.
Janni G, Lappi DA, Ohara PT, Jasmin L (1999) CTB-saporin induced demyelinating myelopathy in the rat. Neuroscience 1999 Abstracts 731.2. Society for Neuroscience, Miami, FL.
Summary: In designing a rat model of demyelinating disease, we have used a newly developed neurotoxin, the B fragment of cholera toxin (CTB) linked to the potent ribosome inactivating protein saporin. Saporin linked to CTB targets cell expressing ganglioside GM1 on their surface, mainly Schwann cells, oligodendrocytes, and to a lesser degree neurons. After binding to GM1, CTB-Saporin is rapidly endocytosed and induces cell death. We demonstrate that intrathecal injection of 1 µg in 5 µl of CTB-Saporin at the lumbar level produces a demyelinating disease of the spinal cord. Behaviorally, this disease is characterized by an ascending paralysis that progresses most prominently from day 7 to day 14 post-treatment. In approximately half of the animals, the disease progresses to the brainstem, while in the others the disease regresses spontaneously, leaving these animals with only a moderate residual neurologic deficit. Histologically and ultrastructurally, the spinal pathology is characterized by a loss of myelin and oligodendroglyocytes as well as an immune response involving circulating leukocytes. Immunostaining shows the presence of CD8 immunopositive T lymphocytes but not CD4 T lymphocytes. We therefore conclude that CTB-Saporin induced demyelination involves an immune, but not an autoimmune mediated component in addition to the direct cytotoxic effect. Supported by Georgetown University.
Related Products: CTB-SAP (Cat. #IT-14)
Retrogradely transported CTB-saporin kills sympathetic preganglionic neurons.
Llewellyn-Smith IJ, Martin CL, Arnolda LF, Minson JB (1999) Retrogradely transported CTB-saporin kills sympathetic preganglionic neurons. Neuroreport 10(2):307-312. doi: 10.1097/00001756-199902050-00019
Related Products: CTB-SAP (Cat. #IT-14)